Calixarene: A new architecture in the analytical and pharmaceutical technology

Journal of Scientific and Industrial Research

Volumn 71, Issue 1, 2012, Pages 21-26

  Shah, M D ^a   Agrawal, Y K ^a  

^a GUJARAT FORENSIC SCIENCES UNIVERSITY   (India)

Author keywords

Calixarene; Drug delivery; Pharmaceutical applications

Indexed keywords

DRUG; DRUG DEVELOPMENT; ION; MOLECULAR ANALYSIS; ORGANIC COMPOUND; PHARMACEUTICAL INDUSTRY;

EID: 84855373623     PISSN: 00224456     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (100)

1. Abdulkadir S & Mustafa Y, Chiral calixarenes, Turk J Chem, 33 (2009) 159-200.
2. Princy J & Shobana M, Lower rim substituted calixarenes and their applications, Bioinorganic Chemistry and Applications, 2007 (2007) 1-16.
3. nd edn (Royal Society of Chemistry, Cambridge) 2008, 24-115.
4. Robert P & Roger L, The potential industrial applications of calixarenes, Pure App Chem, 65(1993) 1549-1559.
5. Nakamoto Y & Ishida S, Calix [7] arene from 4-tert-butylphenol and formaldehyde, Makromol Chem-Rapid Commun, 3 (1982) 705.
6. Sang W & Jung D, Calixarene derivative as a tool for highly sensitive detection and oriented immobilization of proteins in a microarray format through noncovalent molecular interaction, Faseb J Exp, 19 (2005) 1335-1337.
7. Gutsche D, Calixarenes Revisited (Royal Society of Chemistry, Cambridge) 1998, 10-144.
8. Design and applications of new organic functional materials, in Taibah International Chemistry Conference-2009, 23-25 March 2009.
9. Wei A, Calixarene encapsulated nanoparticles: self-assembly into functional nanomaterials, Chemcomm, 15 (2006) 1581-1591.
10. Vandna A, Har Mohindra C & Suneel P, Calixarenes as sensor materials for recognition and separation of metal ions, ARKIVOC, 2007 (2007) 172-200.
11. Rappoport Z, The chemistry of Phenols (John Wiley & Sons, West Sussex) 2003, 1369-1402.
12. Mita N, Soluble calixarene derivative and films thereof, U S Pat 5143784, 1992.
13. Sihyun H, Theoretical study on the conformations of homooxacalix[4]arenas, Bull Korean Chem Soc, 25 (2004) 1911.
14. Lai X H & Wu C, Preparation and chromatographic characteristics of calix[4]arene polysiloxane as stationary phases for capillary gas chromatography, Chromatographia, 50 (1999) 82-88.
15. Vicens J & Bohmer V, Calixarenes: a versatile class of macrocyclic compounds, (Kluwer Academic Publication, Dordrecht) 1991, 211-231.
16. Wang Q, Li Y & Wu G S, ESR study of calix [4] arene by spintrapping method, Appl Magnetic Resonance, 18 (2000) 419-424.
17. David C, Helene C, Yannick R, Michel G & Olivia R, Ipso chlorosulfonylation of calixarenes: A powerful tool for the selective functionalization of the large rim, J Org Chem, 71 (2006) 4059-4065.
18. Agrwal Y K, Pancholi J & Vyas J, Design and synthesis of calixarene, J Sci Ind Res, 68 (2009) 745-768.
19. Oksana D & Kinga S, Solid-state interactions of calixarenes with biorelevant molecules, Chem Commun, 39 (2009) 5799-5813.
20. Wanda S & Malgorzata D, Calixarene complexes with soft metal ions, ARKIVOC, 2008 (2008) 87-127.
21. Mohammed-Ziegler I, Kubinyi M, Grofcsik A, Grun A & Bitter I, Spectroscopic study of complex formation between aliphatic amines and chromogenic calix[4]arene derivatives, J Mol Struct, 480 (1999) 289-292.
22. Dospil G & Schatz J, Synthesis and characterization of imidazole-substituted calix[4]arenes as simple enzyme mimics with acyltransferase activity, Tetrahedron Lett, 42 (2001) 7837-7840.
23. Gunnlaugsson T & Davies M S, Rapid hydrolytic cleavage of the mRNA model compound HPNP by glycine based macrocyclic lanthanide ribonuclease mimics, J Chem Soc Chem Commun, 18 (2002) 2136-2137.
24. Putnam W C & Bashkin J K, De novo synthesis of artificial ribonucleases with benign metal catalysts, J Chem Sot Chem Commun, 9 (2000) 767-768.
25. Ming Y T, Feng Y Z, Li W, Ying G J & Fa S, Supramolecular interaction between water-soluble cali[4]xarene and ATP-the catalysis of calix[4]arene for hydrolysis of ATP, Spectrochimica Acta Part A, 58 (2002) 3033-3038.
26. Ashkenasy G, Margulies D, Felder C E, Shanzer A & Powers L S, Bidentate Ligation of heme analogues; Novel biomimetics of the peroxidase active site, Chem Eur J, 8 (2002) 4017-4026.
27. Cram D J, Stewart K D, Goldberg I & Trueblood K N, Complementary solutes enter nonpolar preorganized cavities in lipophilic noncomplementary media, J Am Chem Soc, 107 (1985) 2574-2575.
28. Molard Y, Bureau C, Lopez H P, Lamartine R & De Vains J B, Synthesis of calix[4]arene podands bearing two and four histidine or glycine groups at the lower rim. Complexation properties towards cobalt (II) chloride, Tetrahedron Lett, 40 (1999) 6383-6387.
29. Agrawal Y K & Bhatt H, Calixarenes and their biomimetic applications, Bioinorganic Chem Appl, 2 (2004) 3-4.
30. Klyachina M A, Boyko V I, Yakovenko A V, Babich L G, Shlykov S G et al, Calix [4] arene n-chalconeamides: synthesis and influence on Mg2+, ATP-dependent Ca2+ accumulation in the smooth muscle subcellular structures, J Inclu Phenom Macrocycl Chem, 60 (2008) 1-2.
31. Buzaneva E & Scarf P, Frontiers of Multifunctional Nanosystems (Kluwer Academic Publishers, Netherland) 2002, 347-431.
32. Kalchenko V I, Koshetsi A, Matsas E P, Kopylov O N, Solovyov A et al, Calixarene based QCM sensors array and it's response to volatile organic vapours, Mater Sci, 20 (2002) 73-88.
33. Filenko D, Kazantseva Z, Ivanova K, Rabinovych O, Kukla A et al, Calixarene-coated nanoparticle gold films for chemical recognition system, in Proc IEEE Sensors 2004 Conf (Vienna, Austria) 24-27 October 2004.
34. Www.ioch.kiev.ua/calix/
35. Bocchinfuso G, Mazzuca C, Saracini C, Venanzi M, Micheli L et al, Receptors for organochlorine pesticides based on calixarenes, Microchimica Acta, 163 (2008) 3-4.
36. Grady T, Joyce T, Smyth M R, Harris S J & Diamond D, Chiral resolution of the enantiomers of phenylglycinol using S-dinaphthylprolinol calix[4]arene by capillary electrophoresis and fluorescence spectroscopy, Anal Comm, 35 (1998) 123-125.
37. Lynam C, Jennings K, Nolan K, Kane P, Mckervey M A et al, Tuning and enhancing enantioselective quenching of calixarene hosts by chiral guest amines, Anal Chem, 74 (2002) 59-66.
38. Marra A, Scherrmann M C, Dondoni A, Casnati A, Minari P et al, Synthesis and properties of O-glycosyl calix [4] arenes (Calixsugars), Chem Eur J, 3 (1997) 1774-1782.
39. Marra A, Scherrmann M C, Dondoni A, Casnati A, Minari P et al, Sugar calixarenes: Preparation of calix [4] arenes substituted at the lower and upper rims with O-glycosyl groups, Angew Chem Int Ed Engl, 33 (2003) 2479-2481.
40. Jennings K & Diamond D, Enantioselective molecular sensing of aromatic amines using tetra-(S)-di-2-naphthylprolinol calix[4]arene, Analyst, 126 (2001) 1063-1067.
41. Pu L, Fluorescence of organic molecules in chiral recognition, Chem Rev, 104 (2004) 1687-1716.
42. Lin J, Li Z B, Zhang H C & Pu L, Highly enantioselective fluorescent recognition of á-amino acid derivatives, Tetrahedron Lett, 45 (2004) 103-106.
43. Dienst E, Bakker W I, Engbersen J F J, Verboom W & Reinhoudt D N, Calixarenes, chemical chameleons, Pure Appl Chem, 65 (1993) 387-392.
44. Ashwin M, Calixarene conjugates useful as MRI and CT diagnostic imaging agents, U S Pat 56226, 1994.
45. Lalor R, Johnson H B, Redshaw C, Matthews S E & Mueller A, Cellular uptake of a fluorescent calix[4]arene derivative, J Am Chem Soc, 130 (2008) 2892-2893.
46. Calixarene chemists develop CJD test. A supplement providing a snapshot of the latest developments in chemical biology (Royal Society of Chemistry, London) 05 April 2006.
47. Geraci C, Consoli G M L, Galante E, Bousquet E, Pappalardo M et al, Calix [4] arene decorated with four Tn antigen glycomimetic units and P3CS immune adjuvant: Synthesis, characterization, and anticancer immunological evaluation, Bioconjugate Chem, 19 (2008) 751-758.
48. Oh S W, Moon J D, Lim H J, Park S Y, Park J et al, Calixarene derivative as a tool for highly sensitive detection and oriented immobilization of proteins in a microarray format through noncovalent molecular interaction, FASEB J Exp, 19 (2005) 1335-1337.
49. Geraci C, Consoli G M L, Galante E, Bousquet E, Pappalardo M et al, Calix[4]arene decorated with four Tn antigen glycomimetic units and P3CS immunoadjuvant: synthesis, characterization, and anticancer immunological evaluation, Bioconjugate Chem, 19 (2008) 751-758.
50. Mccarrick M, Wu B, Harris S J, Diamond D, Barrett G et al, Novel chromogenic ligands for lithium and sodium based on calix [4] arene tetraesters, J Chem Soc Chem Commun, 18 (1992) 1287-1289.
51. Mccarrick M, Wu B, Harris S J, Diamond D, Barrett G et al, Assessment of three azophenol calix[4]arenas as chromogenic ligands for optical detection of alkali metal ions, Analyst, 118 (1998) 1127-1130.
52. Grady T, Butler T, Maccraith B D, Diamond D & McKervey M A, Optical sensor for gaseous ammonia with tunable sensitivity, Analyst, 122 (1997) 803-806.
53. Ganjali S T, Zadmard R, Zeyaei M, Rahnama K, Faridbod F et al, Synthesis of a new calix [4] arene and its application in construction of a highly selective silver ion-selective membrane electrode, Res Lett Org Chem, DOI 601089, 2009.
54. F. Cadogan, P. Kane & McKervey M A, Lead-selective electrodes based on calixarene phosphine oxide derivatives, Anal Chem, 71 (1999) 5544-5550.
55. Arrigan D W M, Svehla G, Harris S J & McKervey M A, Use of calixarenes as modifiers of carbon paste electrodes for voltammetric analysis, Electroanalysis, 6 (2005) 97-106.
56. Arrigan D W M, Svehla G, Harris S J & McKervey M A, Stripping voltammetry with a polymeric calixarene modified carbon paste electrode, Anal Proc, 29 (1992) 27.
57. Ozmen E, Erdemir S, Yilmaz M & Bahadir M, Removal of carcinogenic direct azo dyes from aqueous solutions using calix[n]arene derivatives, CLEAN-Soil, Air, Water, 35 (2007) 612-616.
58. Oh M, Kim K & Lee J, Polymeric waveguide biosensors with calixarene monolayer for detecting potassium ion concentration, Appl Phys Lett, 89 (2006) 251104.
59. Lai G, Zhang H & Jin C, Electrocatalysis and voltammetric determination of dopamine at a calix[4]arene crown-4 ether modified glassy carbon electrode, Electroanalysis, 19 (2007) 496-501.
60. Vicens J & Harrowfield J, Calixarene in the Nanoworld (Springer, Netherland) 2007, 63-151.
61. Kubinyi M, Mohammed-Ziegler I, Grofcsik A, Bitter I & Jones W J, Spectroscopic study of complex formation between alkali metal ions and chromogenic calixarene derivatives, J Mol Struct, 543 (1997) 408-409.
62. Glennon J D, Horne E, O'Connor K, Kearney G A, Harris S & McKervey M A, Chromatographic selectivity for amino acid esters and alkali metal ions on a silica bonded calix[4]arene tetraester stationary phase, Anal Proc, 31 (1994) 33-35.
63. Millership J S, Mckervey M A & Russell J A, Complexation and chromatographic studies involving water-soluble calixarenes and nitrophenols, Chromatographia, 48 (1998) 402-406.
64. Danylyuk O & Suwinska K, Solid-state interactions of calixarenes with biorelevant molecules, Chem Commun, 39 (2009) 5799-5813.
65. Gurusamy S, Park J H, Kim K & Kwon I, Nanomedicine: An emerging modality based on nanotechnology for therapy and diagnosis, J Korean Ind Eng Chem, 18 (2007) 199-204.
66. Yang W & De Villiers M M, Effect of 4-sulphonato-calix [n] arenes and cyclodextrins on the solubilization of niclosamide, a poorly water soluble anthelmintic, AAPS J, 7 (2005), E241-E248.
67. Alekseeva E A, Lukyanenko A P, Kravchenko I A & Nevarko N A, Preparation and biological properties of inclusion compounds of calix[4]arene and 1, 4-benzodiazepinone derivatives, Russ J Gen Chem, 78 (2008) 949-953.
68. Fatima A, Fernandes S A & Sabino A A, Calixarenes as new platform for drug design, Curr Drug Discov Technol, 6 (2009) 151-170.
69. Cherenok S, Vovk A, Muravyova I, Shivanyuk A, Kukhar V, Lipkowski J et al, Calix[4]arene á-aminophosphonic acids: Asymmetric synthesis and enantioselective inhibition of an alkaline phosphatase, Org Lett, 8 (2006) 549-552.
70. Rodik R, Boiko V, Danylyuk O, Suwinska K, Tsymbal I et al, Calix [4]arenesulfonylamidines. Synthesis, structure and influence on Mg2+, ATP-dependent calcium pumps, Tetrahedron Lett, 46 (2005) 7459-7462.
71. Cornforth J W, Hart P D, Nicholls G A, Rees R J W & Stock J A, Antituberculous effects of certain surface-active polyoxyethylene ethers, Br J Pharmacol, 10 (1955) 73-88.
72. Shinkai S, Mori S, Tsubaki K, Sone T & Takashi M O, New syntheses of calixarene-p-sulphonates and p-nitrocalixarenes, J Chem Soc Perkin Trans 1, 11 (1987) 2297.
73. Shinkai S, Mori S, Tsubaki K, Sone T & Takashi M O, New water-soluble host molecules derived from calix[6]arene, Tetrahedron Lett, 25 (1984) 5315-5318.
74. Atwood J L, Bridges R J, Juneja R K & Singh A K, Calixarene chloride-channel blockers, U S Pat 5,489,612, 1996.
75. Mourer M, Psychogios N, Laumond G, Aubertin A M & Regnouf-de-Vains J B, Sy nthesis and anti-HIV evaluation of water-soluble calixarene-based bithiazolyl podands, Bioorg Med Chem, Doi:10.1016/j.bmc.2009.11.016, 2009.
76. Colston M J, Hailes H C, Stavropoulos E, Herve A C, Herve G et al, Antimycobacterial calixarenes enhance innate defense mechanisms in murine macrophages and induce control of mycobacterium tuberculosis infection in mice, Infect Immun, 72 (2004) 6318-6323.
77. Dibama H M, Clarot I, Fontanay S, Salem A B, Mourer M et al, Towards calixarene-based prodrugs: Drug release and antibacterial behaviour of a water-soluble nalidixic acid/calix[4]arene ester adduct, Bioorg Med Chem Lett, 19 (2009) 2679-2682.
78. Menger F M, Bian J, Sizova E, Martinson D E & Seredyuk V A, Bolaforms with fourteen galactose units: A proposed sitedirected cohesion of cancer cells, Org Lett, 6 (2004) 261-264.
79. Coleman A W, Perret F, Moussa A, Dupin M, Guo Y et al, Calix[n]arenes as protein sensors, Top Curr Chem, 277 (2007) 31-88.
80. Coveney D C & Benjamin, Calixarene-derivatives having anti-viral activity, EP1367044, 2008.
81. Paquet V, Zumbuehl A & Carreira E M, Biologically Active amphotericin B-calix [4] arene conjugates, Bioconjugate Chem, 17 (2006) 1460-1463.
82. Spagnul A, Bouvier-Capely C, Phan G, Rebiere F & Fattal E, Calixarene-entrapped nanoemulsion for uranium extraction from contaminated solutions, J Pharmac Sci, 99 (2010) 1375-1383.
83. Balzani V & Cola L D, Supramolecular Chemistry (Kluwer Academics, Boston) 1992, 57-133.
84. Jenning V, Thunemann A F & Gohla S H, Characterisation of a novel solid lipid nanoparticle carrier system based on binary mixtures of liquid and solid lipids, Int J Pharm, 199 (2000) 167-177.
85. Shahgaldian P, Silva E D, Coleman A W, Rather B & Zaworotko M, Para-acyl-calix-arene based solid lipid nanoparticles (SLNs): A detailed study of preparation and stability parameters, Int J Pharmac, 253 (2003) 23-38.
86. Shahgaldian P, Gualbert J & Coleman A W, A first approach to the study of calixarene solid lipid nanoparticle (SLN) toxicity, J Inclus Phenom Macrocycl Chem, 46 (2003) 175-177.
87. Shahgaldian P, Gualbert J & Coleman A W, Solid lipid nanoparticles (SLNs): Preparation and properties of calix[4]resorcinarene derived systems, J Inclus Phenom Macrocycl Chem, 48 (2004) 37-44.
88. Shahgaldian P, Gualbert J & Coleman A W, A study of the freeze-drying conditions of calixarene based solid lipid nanoparticles, Eur J Pharmac Biopharmac, 55 (2003) 181-184.
89. Higler I, Timmerman P, Verboom W & Reinhoudt D N, Combination of calix[4]arenes and resorcin[4]arenes for the complexation of steroids, J Org Chem, 61 (1996) 5920.
90. Yang W & De Villiers M M, The solubilization of the poorly water soluble drug nifedipine by water soluble 4-sulphonic calix[n]arenes, Eur J Pharm Biopharm, 58 (2004) 629-636.
91. Matthews S, Lalor R & Payerne E, Multivalent calix[4]arene dendrimers for lectin targeted drug delivery. AAPS. www.aapsj.org/abstracts/AM_2005/Staged/aaps2005-001363.PDF, 2005.
92. Parini C, Colombi S & Casnati A, Solid state interaction of steroids with calixarenes I. A preliminary FTIR and DSC study on 4-en-3-keto-steroids, J Incl Phenom, 18 (1994) 341-351.
93. Pojarova M, Ananchenko G S, Udachin K A, Daroszewska M, Perret F et al, Solid lipid nanoparticles of p-hexanoyl calix[4]arene as a controlling agent in the photochemistry of a sunscreen blocker, Chem Mater, 18 (2006) 5817-5819.
94. Lee M, Lee S & Jiang L, Stimuli-responsive supramolecular nanocapsules from amphiphilic calixarene assembly, J Am Chem Soc, 126 (2004) 12724-12725.
95. Alekseeva E A, Andronati K A, Mazepaa A V, Gren A I, Pavlovskaya T V et al, Calix[4]arenes containing benzodiazepinone fragments at the lower rim, Russ J Gen Chem, 76 (2006) 1464-1467.
96. Corbellini F, Costanzo L D, Crego-Calama M, Geremia S & Reinhoudt R N, Guest encapsulation in a water-soluble molecular capsule based on ionic interactions, J Am Chem Soc, 125 (2003) 9946-9947.
97. Gansey M, Haan A S, Bos E S, Verboom W & Reinhoudt D N, Conjugation, immunoreactivity, and immunogenicity of calix[4]arenes; Model study to potential calix[4]arene based Ac3+ chelators, Bioconjugate Chem, 10 (1999) 613-623.
98. Gualbert J, Shahgaldian P & Coleman A W, Interactions of amphiphilic calix[4]arene based solid lipid nanoparticles with bovine serum albumin, Int J Pharmac, 257 (2003) 69-73.
99. Atul P, Suresh P V & Kailash C G, Nano-vectors for efficient liver specific gene transfer, Int J Nanomed, 3 (2008) 31-49.
100. Paclet M, Rousseau C, Yannick C & Coleman A W, An absence of non-specific immune response towards para-sulphonatocalix[n]arenes, J Inclus Phenom Macrocycl Chem, 55 (2006) 353-357.